Quantitation of tumor vessel density in CD31 immunostained sections revealed an ~70–80% reduction in vessel area in LLC tumor allografts from either of the Cds2 vMO-treated animals compared to controls (Fig. 5e–h). The gene discussed is PECAM1; the disease is neoplasm.